BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 12170972)

  • 21. HIV vaccines: new frontiers in vaccine development.
    Duerr A; Wasserheit JN; Corey L
    Clin Infect Dis; 2006 Aug; 43(4):500-11. PubMed ID: 16838241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prime-boost strategies in DNA vaccines.
    Dale CJ; Thomson S; De Rose R; Ranasinghe C; Medveczky CJ; Pamungkas J; Boyle DB; Ramshaw IA; Kent SJ
    Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection.
    Fernández-Cruz E; Navarro J; Rodríguez-Sainz C; Gil J; Moreno S; González-Lahoz J; Carbone J
    Expert Rev Vaccines; 2003 Dec; 2(6):739-52. PubMed ID: 14711358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV vaccine research in Thailand: lessons learned.
    Pitisuttithum P
    Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic vaccine trails in Thailand.
    Churdboonchart V
    J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bringing DNA vaccines closer to commercial use.
    Carvalho JA; Prazeres DM; Monteiro GA
    IDrugs; 2009 Oct; 12(10):642-7. PubMed ID: 19790015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological considerations in planning HIV preventive vaccine trials.
    Esparza J; Burke D
    AIDS; 2001; 15 Suppl 5():S49-57. PubMed ID: 11816175
    [No Abstract]   [Full Text] [Related]  

  • 28. What about the ethics?
    Wolf LE; Lo B
    West J Med; 1999; 171(5-6):365-6. PubMed ID: 10639878
    [No Abstract]   [Full Text] [Related]  

  • 29. New oral DNA vaccine funded for trials.
    James JS
    AIDS Treat News; 2000 Jun; (344):3. PubMed ID: 12170972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV/AIDS vaccines: 2007.
    Robinson HL
    Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity.
    Hinkula J
    Expert Rev Vaccines; 2007 Apr; 6(2):203-12. PubMed ID: 17408370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV/AIDS vaccines: a need for new concepts?
    Girard MP; Bansal GP
    Int Rev Immunol; 2008; 27(6):447-71. PubMed ID: 19065351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of multicomponent DNA vaccination strategies against HIV.
    Kim JJ; Weiner DB
    Curr Opin Mol Ther; 1999 Feb; 1(1):43-9. PubMed ID: 11249683
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.